These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34845060)

  • 1. Diabetes technologies for children and adolescents with type 1 diabetes are highly dependent on coverage and reimbursement: results from a worldwide survey.
    Dos Santos TJ; Dave C; MacLeish S; Wood JR
    BMJ Open Diabetes Res Care; 2021 Nov; 9(2):. PubMed ID: 34845060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent heterogeneity in diabetes technology reimbursement for children with type 1 diabetes: The SWEET perspective.
    Sumnik Z; Szypowska A; Iotova V; Bratina N; Cherubini V; Forsander G; Jali S; Raposo JF; Stipančic G; Vazeou A; Veeze H; Lange K;
    Pediatr Diabetes; 2019 Jun; 20(4):434-443. PubMed ID: 30773756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current status of continuous subcutaneous insulin infusion and continuous glucose monitoring systems in the Community of Madrid].
    Arranz Martín A; Calle Pascual A; Del Cañizo Gómez FJ; González Albarrán O; Lisbona Gil A; Botella Serrano M; Pallardo Sánchez LF;
    Endocrinol Nutr; 2015 Apr; 62(4):171-9. PubMed ID: 25726367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons learned from a pilot RCT of simultaneous versus delayed initiation of continuous glucose monitoring in children and adolescents with type 1 diabetes starting insulin pump therapy.
    Olivier P; Lawson ML; Huot C; Richardson C; Nakhla M; Romain J
    J Diabetes Sci Technol; 2014 May; 8(3):523-8. PubMed ID: 24876616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.
    ; Weinzimer S; Xing D; Tansey M; Fiallo-Scharer R; Mauras N; Wysocki T; Beck R; Tamborlane W; Ruedy K
    Pediatr Diabetes; 2009 Apr; 10(2):91-6. PubMed ID: 19175899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus.
    Rigo RS; Levin LE; Belsito DV; Garzon MC; Gandica R; Williams KM
    J Diabetes Sci Technol; 2021 Jul; 15(4):786-791. PubMed ID: 32389062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost, Hassle, and On-Body Experience: Barriers to Diabetes Device Use in Adolescents and Potential Intervention Targets.
    Messer LH; Tanenbaum ML; Cook PF; Wong JJ; Hanes SJ; Driscoll KA; Hood KK
    Diabetes Technol Ther; 2020 Oct; 22(10):760-767. PubMed ID: 32163719
    [No Abstract]   [Full Text] [Related]  

  • 9. Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives.
    Pickup JC; Ford Holloway M; Samsi K
    Diabetes Care; 2015 Apr; 38(4):544-50. PubMed ID: 25552422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Executive Functions and Adherence to Continuous Glucose Monitoring in Children and Adolescents with Type 1 Diabetes.
    Farfel A; Liberman A; Yackobovitch-Gavan M; Phillip M; Nimri R
    Diabetes Technol Ther; 2020 Apr; 22(4):265-270. PubMed ID: 31789577
    [No Abstract]   [Full Text] [Related]  

  • 11. Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes.
    Lin MH; Connor CG; Ruedy KJ; Beck RW; Kollman C; Buckingham B; Redondo MJ; Schatz D; Haro H; Lee JM; Tamborlane WV; Wood JR;
    Diabetes Technol Ther; 2013 Nov; 15(11):929-34. PubMed ID: 23869706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).
    Moser O; Riddell MC; Eckstein ML; Adolfsson P; Rabasa-Lhoret R; van den Boom L; Gillard P; Nørgaard K; Oliver NS; Zaharieva DP; Battelino T; de Beaufort C; Bergenstal RM; Buckingham B; Cengiz E; Deeb A; Heise T; Heller S; Kowalski AJ; Leelarathna L; Mathieu C; Stettler C; Tauschmann M; Thabit H; Wilmot EG; Sourij H; Smart CE; Jacobs PG; Bracken RM; Mader JK
    Diabetologia; 2020 Dec; 63(12):2501-2520. PubMed ID: 33047169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis.
    Wojciechowski P; Ryś P; Lipowska A; Gawęska M; Małecki MT
    Pol Arch Med Wewn; 2011 Oct; 121(10):333-43. PubMed ID: 22045094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Current Diabetes Technology Improve Metabolic Control? A Cross-Sectional Study on the Use of Insulin Pumps and Continuous Glucose Monitoring Devices in a Nationwide Pediatric Population.
    Bratke H; Margeirsdottir HD; Assmus J; Njølstad PR; Skrivarhaug T
    Diabetes Ther; 2021 Sep; 12(9):2571-2583. PubMed ID: 34389930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CGM Benefits and Burdens: Two Brief Measures of Continuous Glucose Monitoring.
    Messer LH; Cook PF; Tanenbaum ML; Hanes S; Driscoll KA; Hood KK
    J Diabetes Sci Technol; 2019 Nov; 13(6):1135-1141. PubMed ID: 30854886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin pumps and continuous glucose monitoring (CGM) in preschool and school-age children: how schools can integrate technology.
    Bratina N; Battelino T
    Pediatr Endocrinol Rev; 2010 Aug; 7 Suppl 3():417-21. PubMed ID: 20877256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and economic benefits of integrated pump/CGM technology therapy in patients with type 1 diabetes in Colombia.
    Gomez AM; Alfonso-Cristancho R; Orozco JJ; Lynch PM; Prieto D; Saunders R; Roze S; Valencia JE
    Endocrinol Nutr; 2016 Nov; 63(9):466-474. PubMed ID: 27595241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving pediatric endocrinology trainees' knowledge about insulin pumps and continuous glucose monitors with online spaced education: Technology Knowledge Optimization in T1D (TeKnO T1D).
    Marks BE; Waldman G; Reardon K; Terrio S; Kumar A; Stafford DEJ; Garvey KC; Wolfsdorf JI
    Pediatr Diabetes; 2020 Aug; 21(5):814-823. PubMed ID: 32222056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequencies of dermatological complications in children using insulin pumps or sensors.
    Berg AK; Olsen BS; Thyssen JP; Zachariae C; Simonsen AB; Pilgaard K; Svensson J
    Pediatr Diabetes; 2018 Jun; 19(4):733-740. PubMed ID: 29484783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.